Is immunostaining with HAM56 antibody useful in identifying ovarian origin of metastatic adenocarcinomas?
- 1 January 1997
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 28 (1) , 91-94
- https://doi.org/10.1016/s0046-8177(97)90285-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Human malignant astrocytes express macrophage phenotypeJournal of Neuroimmunology, 1995
- Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen.Journal of Clinical Pathology, 1994
- Dermatofibroma: Superficial fibrous proliferation with reactive histiocytes. A multiple immunostaining analysisCancer, 1994
- Metastatic Adenocarcinoma of an Unknown Primary Site: A Comparison of the Relative Contributions of Morphology, Minimal Essential Clinical Data and CEA Immunostaining StatusAmerican Journal of Clinical Pathology, 1993
- Use of tumour marker immunoreactivity to identify primary site of metastatic cancer.BMJ, 1993
- Metastatic Ovarian Carcinoma of Large Intestinal Origin Simulating Primary Ovarian Carcinoma: A Clinicopathologic Study of 25 CasesAmerican Journal of Clinical Pathology, 1992
- Malignancies of undertermined primary originDisease-a-Month, 1992
- Metastatic Tumors of Unknown Origin: An Ultrastructural Analysis of 265 CasesUltrastructural Pathology, 1987
- An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.Journal of Clinical Pathology, 1979
- Treatment of the patient with adenocarcinoma of unknown originCancer, 1972